Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 4, 2012, Pages 920-926

  Barbieri, Antonio ^a   Palma, Giuseppe ^a   Rosati, Alessandra ^b   Giudice, Aldo ^a   Falco, Antonia ^b   Petrillo, Antonella ^a   Petrillo, Mario ^a   Bimonte, Sabrina ^c   Di Benedetto, Maria ^d   Esposito, Giuseppe ^a   Stiuso, Paola ^e   Abbruzzese, Alberto ^e   Caraglia, Michele ^e   Arra, Claudio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

B16f10; eNOS melanoma; NOS isoforms; Stress

Indexed keywords

ANIMALIA; MURINAE; MUS;

BETA ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL; ARTICLE; C57BL MOUSE; CHRONIC DISEASE; ENZYMOLOGY; EXPERIMENTAL MELANOMA; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION;

ANIMALS; CHRONIC DISEASE; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84867870227     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01375.x     Document Type: Article

References (36)

1. Dhabhar FS, McEwen BS. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav Immun. 1997; 11: 286-306.
2. Montoro J, Mullol J, Jauregui I, et al. Stress and allergy. J Investig Allergol Clin Immunol. 2009; 19: 40-7.
3. Vere CC, Streba CT, Streba LM, et al. Psychosocial stress and liver disease status. World J Gastroenterol. 2009; 15: 2980-6.
4. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006; 6: 240-8.
5. Chida Y, Hamer M, Wardle J, et al. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008; 5: 466-75.
6. Desaive P, Ronson A. Stress spectrum disorders in oncology. Curr Opin Oncol. 2008; 20: 378-85.
7. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004; 5: 617-25.
8. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumour growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006; 12: 939-44.
9. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol. 2002; 53: 503-14.
10. Forstermann U, Pollock JS, Tracey WR, et al. Isoforms of nitric-oxide synthase: purification and regulation. Methods Enzymol. 1994; 233: 258-64.
11. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006; 6: 521-34.
12. Roberts DD, Isenberg JS, Ridnour LA, et al. Nitric oxide and its gatekeeper thrombospondin-1 in tumour angiogenesis. Clin Cancer Res. 2007; 13: 795-8.
13. Singh JP. Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis. Curr Opin Investig Drugs. 2007; 8: 736-41.
14. Choi JY, Lee KM, Noh DY, et al. Genetic polymorphisms of eNOS, hormone receptor status, and survival of breast cancer. Breast Cancer Res Treat. 2006; 100: 213-8.
15. Lu J, Wei Q, Bondy ML, et al. Promoter polymorphism (-786t > C) in theendothelial nitric oxide synthase gene isassociated with risk of sporadic breastcancer in non-Hispanic white women ageyounger than 55 years. Cancer. 2006; 107:2245-53.
16. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007; 67: 1407-10.
17. Seya Y, Fukuda T, Isobe K, et al. Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells. Eur J Pharmacol. 2006; 553: 54-60.
18. Kou R, Michel T. Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. J Biol Chem. 2007; 282: 32719-29.
19. Figueroa XF, Poblete I, Fernandez R, et al. NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors. Am J Physiol Heart Circ Physiol. 2009; 297: H134-43.
20. Sheridan JF, Feng NG, Bonneau RH, et al. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J Neuroimmunol. 1991; 31: 245-55.
21. Thaker PH, Sood AK. Neuroendocrine influences on cancer biology. Semin Cancer Biol. 2008; 18: 164-70.
22. Frick LR, Arcos ML, Rapanelli M, et al. Chronic restraint stress impairs T cell immunity and promotes tumour progression in mice. Stress. 2009; 12: 134-43.
23. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001; 2: 149-56.
24. Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med. 2005; 26: 33-65.
25. Sabban EL, Hebert MA, Liu X, et al. Differential effects of stress on gene transcription factors in catecholaminergic systems. Ann N Y Acad Sci. 2004; 1032: 130-40.
26. Nanni S, Benvenuti V, Grasselli A, et al. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest. 2009; 119: 1093-108.
27. Ben-Eliyahu S, Page GG, Schleifer SJ. Stress, NK cells, and cancer: still a promissory note. Brain Behav Immun. 2007; 21: 881-7.
28. Yang EV, Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumour cells. Cancer Res. 2006; 66: 10357-64.
29. Babaei S, Teichert-Kuliszewska K, Zhang Q, et al. Angiogenic actions of angiopoietin-1 require endotheliumderived nitric oxide. Am J Pathol. 2003; 162: 1927-36.
30. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001; 98: 2604-9.
31. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997; 99: 2625-34.
32. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumour biology: the two sides of the same coin. Semin Cancer Biol. 2005; 15: 277-89.
33. Decker NK, Abdelmoneim SS, Yaqoob U, et al. Nitric oxide regulates tumour cell cross-talk with stromal cells in the tumour microenvironment of the liver. Am J Pathol. 2008; 173: 1002-12.
34. Lim KH, Ancrile BB, Kashatus DF, et al. Tumour maintenance is mediated by eNOS. Nature. 2008; 452: 646-9.
35. Lahdenranta J, Hagendoorn J, Padera TP, et al. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res. 2009; 69: 2801-8.
36. Caraglia M, Giuberti G, Marra M, et al. Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis. 2011; 2: e150; doi: 10.1038/ cddis.2011.34.